Global Glucagon Like Peptide 2 Receptor market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. Get Access Now!

Global Glucagon Like Peptide 2 Receptor Market Size and Outlook 2025-31

The global Glucagon Like Peptide 2 Receptor market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report. According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment. Infinity Market Research newest research report, the Glucagon Like Peptide 2 Receptor Industry Forecast looks at past sales and reviews total world Glucagon Like Peptide 2 Receptor sales in 2024, providing a comprehensive analysis by region and market sector of projected Glucagon Like Peptide 2 Receptor sales for 2025 through 2031. With Glucagon Like Peptide 2 Receptor sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Glucagon Like Peptide 2 Receptor industry. This Insight Report provides a comprehensive analysis of the global Glucagon Like Peptide 2 Receptor landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Glucagon Like Peptide 2 Receptor portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms unique position in an accelerating global Glucagon Like Peptide 2 Receptor market. This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Glucagon Like Peptide 2 Receptor and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Glucagon Like Peptide 2 Receptor. This report presents a comprehensive overview, market shares, and growth opportunities of Glucagon Like Peptide 2 Receptor market by product type, application, key manufacturers and key regions and countries. Segmentation by Type: &nbsp;&nbsp;&nbsp; FE-203799 &nbsp;&nbsp;&nbsp; Glepaglutide &nbsp;&nbsp;&nbsp; GXG-8 &nbsp;&nbsp;&nbsp; HM-15910 &nbsp;&nbsp;&nbsp; Others Segmentation by Application: &nbsp;&nbsp;&nbsp; Short Bowel Syndrome &nbsp;&nbsp;&nbsp; Diabetes &nbsp;&nbsp;&nbsp; Diarrhea &nbsp;&nbsp;&nbsp; Obesity &nbsp;&nbsp;&nbsp; Others This report also splits the market by region: &nbsp;&nbsp;&nbsp; Americas &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; United States &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Canada &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mexico &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Brazil &nbsp;&nbsp;&nbsp; APAC &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; China &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Japan &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Korea &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Southeast Asia &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; India &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Australia &nbsp;&nbsp;&nbsp; Europe &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Germany &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; France &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; UK &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Italy &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Russia &nbsp;&nbsp;&nbsp; Middle East & Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Egypt &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; South Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Israel &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Turkey &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the companys coverage, product portfolio, its market penetration. &nbsp;&nbsp;&nbsp; Hanmi Pharmaceuticals Co Ltd &nbsp;&nbsp;&nbsp; Naia Ltd &nbsp;&nbsp;&nbsp; Takeda &nbsp;&nbsp;&nbsp; Tasly Pharmaceutical Group Co Ltd &nbsp;&nbsp;&nbsp; Zealand Pharma AS Key Questions Addressed in this Report What is the 10-year outlook for the global Glucagon Like Peptide 2 Receptor market? What factors are driving Glucagon Like Peptide 2 Receptor market growth, globally and by region? Which technologies are poised for the fastest growth by market and region? How do Glucagon Like Peptide 2 Receptor market opportunities vary by end market size? How does Glucagon Like Peptide 2 Receptor break out by Type, by Application?

1 Scope of the Report &nbsp;1.1 Market Introduction &nbsp;1.2 Years Considered &nbsp;1.3 Research Objectives &nbsp;1.4 Market Research Methodology &nbsp;1.5 Research Process and Data Source &nbsp;1.6 Economic Indicators &nbsp;1.7 Currency Considered &nbsp;1.8 Market Estimation Caveats 2 Executive Summary &nbsp;2.1 World Market Overview &nbsp;2.1.1 Global Glucagon Like Peptide 2 Receptor Annual Sales 2020-2031 &nbsp;2.1.2 World Current & Future Analysis for Glucagon Like Peptide 2 Receptor by Geographic Region, 2020, 2024 & 2031 &nbsp;2.1.3 World Current & Future Analysis for Glucagon Like Peptide 2 Receptor by Country/Region, 2020, 2024 & 2031 &nbsp;2.2 Glucagon Like Peptide 2 Receptor Segment by Type &nbsp;2.2.1 FE-203799 &nbsp;2.2.2 Glepaglutide &nbsp;2.2.3 GXG-8 &nbsp;2.2.4 HM-15910 &nbsp;2.2.5 Others &nbsp;2.3 Glucagon Like Peptide 2 Receptor Sales by Type &nbsp;2.3.1 Global Glucagon Like Peptide 2 Receptor Sales Market Share by Type (2020-2025) &nbsp;2.3.2 Global Glucagon Like Peptide 2 Receptor Revenue and Market Share by Type (2020-2025) &nbsp;2.3.3 Global Glucagon Like Peptide 2 Receptor Sale Price by Type (2020-2025) &nbsp;2.4 Glucagon Like Peptide 2 Receptor Segment by Application &nbsp;2.4.1 Short Bowel Syndrome &nbsp;2.4.2 Diabetes &nbsp;2.4.3 Diarrhea &nbsp;2.4.4 Obesity &nbsp;2.4.5 Others &nbsp;2.5 Glucagon Like Peptide 2 Receptor Sales by Application &nbsp;2.5.1 Global Glucagon Like Peptide 2 Receptor Sale Market Share by Application (2020-2025) &nbsp;2.5.2 Global Glucagon Like Peptide 2 Receptor Revenue and Market Share by Application (2020-2025) &nbsp;2.5.3 Global Glucagon Like Peptide 2 Receptor Sale Price by Application (2020-2025) 3 Global by Company &nbsp;3.1 Global Glucagon Like Peptide 2 Receptor Breakdown Data by Company &nbsp;3.1.1 Global Glucagon Like Peptide 2 Receptor Annual Sales by Company (2020-2025) &nbsp;3.1.2 Global Glucagon Like Peptide 2 Receptor Sales Market Share by Company (2020-2025) &nbsp;3.2 Global Glucagon Like Peptide 2 Receptor Annual Revenue by Company (2020-2025) &nbsp;3.2.1 Global Glucagon Like Peptide 2 Receptor Revenue by Company (2020-2025) &nbsp;3.2.2 Global Glucagon Like Peptide 2 Receptor Revenue Market Share by Company (2020-2025) &nbsp;3.3 Global Glucagon Like Peptide 2 Receptor Sale Price by Company &nbsp;3.4 Key Manufacturers Glucagon Like Peptide 2 Receptor Producing Area Distribution, Sales Area, Product Type &nbsp;3.4.1 Key Manufacturers Glucagon Like Peptide 2 Receptor Product Location Distribution &nbsp;3.4.2 Players Glucagon Like Peptide 2 Receptor Products Offered &nbsp;3.5 Market Concentration Rate Analysis &nbsp;3.5.1 Competition Landscape Analysis &nbsp;3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025) &nbsp;3.6 New Products and Potential Entrants &nbsp;3.7 Market M&A Activity & Strategy 4 World Historic Review for Glucagon Like Peptide 2 Receptor by Geographic Region &nbsp;4.1 World Historic Glucagon Like Peptide 2 Receptor Market Size by Geographic Region (2020-2025) &nbsp;4.1.1 Global Glucagon Like Peptide 2 Receptor Annual Sales by Geographic Region (2020-2025) &nbsp;4.1.2 Global Glucagon Like Peptide 2 Receptor Annual Revenue by Geographic Region (2020-2025) &nbsp;4.2 World Historic Glucagon Like Peptide 2 Receptor Market Size by Country/Region (2020-2025) &nbsp;4.2.1 Global Glucagon Like Peptide 2 Receptor Annual Sales by Country/Region (2020-2025) &nbsp;4.2.2 Global Glucagon Like Peptide 2 Receptor Annual Revenue by Country/Region (2020-2025) &nbsp;4.3 Americas Glucagon Like Peptide 2 Receptor Sales Growth &nbsp;4.4 APAC Glucagon Like Peptide 2 Receptor Sales Growth &nbsp;4.5 Europe Glucagon Like Peptide 2 Receptor Sales Growth &nbsp;4.6 Middle East & Africa Glucagon Like Peptide 2 Receptor Sales Growth 5 Americas &nbsp;5.1 Americas Glucagon Like Peptide 2 Receptor Sales by Country &nbsp;5.1.1 Americas Glucagon Like Peptide 2 Receptor Sales by Country (2020-2025) &nbsp;5.1.2 Americas Glucagon Like Peptide 2 Receptor Revenue by Country (2020-2025) &nbsp;5.2 Americas Glucagon Like Peptide 2 Receptor Sales by Type (2020-2025) &nbsp;5.3 Americas Glucagon Like Peptide 2 Receptor Sales by Application (2020-2025) &nbsp;5.4 United States &nbsp;5.5 Canada &nbsp;5.6 Mexico &nbsp;5.7 Brazil 6 APAC &nbsp;6.1 APAC Glucagon Like Peptide 2 Receptor Sales by Region &nbsp;6.1.1 APAC Glucagon Like Peptide 2 Receptor Sales by Region (2020-2025) &nbsp;6.1.2 APAC Glucagon Like Peptide 2 Receptor Revenue by Region (2020-2025) &nbsp;6.2 APAC Glucagon Like Peptide 2 Receptor Sales by Type (2020-2025) &nbsp;6.3 APAC Glucagon Like Peptide 2 Receptor Sales by Application (2020-2025) &nbsp;6.4 China &nbsp;6.5 Japan &nbsp;6.6 South Korea &nbsp;6.7 Southeast Asia &nbsp;6.8 India &nbsp;6.9 Australia &nbsp;6.10 China Taiwan 7 Europe &nbsp;7.1 Europe Glucagon Like Peptide 2 Receptor by Country &nbsp;7.1.1 Europe Glucagon Like Peptide 2 Receptor Sales by Country (2020-2025) &nbsp;7.1.2 Europe Glucagon Like Peptide 2 Receptor Revenue by Country (2020-2025) &nbsp;7.2 Europe Glucagon Like Peptide 2 Receptor Sales by Type (2020-2025) &nbsp;7.3 Europe Glucagon Like Peptide 2 Receptor Sales by Application (2020-2025) &nbsp;7.4 Germany &nbsp;7.5 France &nbsp;7.6 UK &nbsp;7.7 Italy &nbsp;7.8 Russia 8 Middle East & Africa &nbsp;8.1 Middle East & Africa Glucagon Like Peptide 2 Receptor by Country &nbsp;8.1.1 Middle East & Africa Glucagon Like Peptide 2 Receptor Sales by Country (2020-2025) &nbsp;8.1.2 Middle East & Africa Glucagon Like Peptide 2 Receptor Revenue by Country (2020-2025) &nbsp;8.2 Middle East & Africa Glucagon Like Peptide 2 Receptor Sales by Type (2020-2025) &nbsp;8.3 Middle East & Africa Glucagon Like Peptide 2 Receptor Sales by Application (2020-2025) &nbsp;8.4 Egypt &nbsp;8.5 South Africa &nbsp;8.6 Israel &nbsp;8.7 Turkey &nbsp;8.8 GCC Countries 9 Market Drivers, Challenges and Trends &nbsp;9.1 Market Drivers & Growth Opportunities &nbsp;9.2 Market Challenges & Risks &nbsp;9.3 Industry Trends 10 Manufacturing Cost Structure Analysis &nbsp;10.1 Raw Material and Suppliers &nbsp;10.2 Manufacturing Cost Structure Analysis of Glucagon Like Peptide 2 Receptor &nbsp;10.3 Manufacturing Process Analysis of Glucagon Like Peptide 2 Receptor &nbsp;10.4 Industry Chain Structure of Glucagon Like Peptide 2 Receptor 11 Marketing, Distributors and Customer &nbsp;11.1 Sales Channel &nbsp;11.1.1 Direct Channels &nbsp;11.1.2 Indirect Channels &nbsp;11.2 Glucagon Like Peptide 2 Receptor Distributors &nbsp;11.3 Glucagon Like Peptide 2 Receptor Customer 12 World Forecast Review for Glucagon Like Peptide 2 Receptor by Geographic Region &nbsp;12.1 Global Glucagon Like Peptide 2 Receptor Market Size Forecast by Region &nbsp;12.1.1 Global Glucagon Like Peptide 2 Receptor Forecast by Region (2026-2031) &nbsp;12.1.2 Global Glucagon Like Peptide 2 Receptor Annual Revenue Forecast by Region (2026-2031) &nbsp;12.2 Americas Forecast by Country (2026-2031) &nbsp;12.3 APAC Forecast by Region (2026-2031) &nbsp;12.4 Europe Forecast by Country (2026-2031) &nbsp;12.5 Middle East & Africa Forecast by Country (2026-2031) &nbsp;12.6 Global Glucagon Like Peptide 2 Receptor Forecast by Type (2026-2031) &nbsp;12.7 Global Glucagon Like Peptide 2 Receptor Forecast by Application (2026-2031) 13 Key Players Analysis &nbsp;13.1 Hanmi Pharmaceuticals Co Ltd &nbsp;13.1.1 Hanmi Pharmaceuticals Co Ltd Company Information &nbsp;13.1.2 Hanmi Pharmaceuticals Co Ltd Glucagon Like Peptide 2 Receptor Product Portfolios and Specifications &nbsp;13.1.3 Hanmi Pharmaceuticals Co Ltd Glucagon Like Peptide 2 Receptor Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.1.4 Hanmi Pharmaceuticals Co Ltd Main Business Overview &nbsp;13.1.5 Hanmi Pharmaceuticals Co Ltd Latest Developments &nbsp;13.2 Naia Ltd &nbsp;13.2.1 Naia Ltd Company Information &nbsp;13.2.2 Naia Ltd Glucagon Like Peptide 2 Receptor Product Portfolios and Specifications &nbsp;13.2.3 Naia Ltd Glucagon Like Peptide 2 Receptor Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.2.4 Naia Ltd Main Business Overview &nbsp;13.2.5 Naia Ltd Latest Developments &nbsp;13.3 Takeda &nbsp;13.3.1 Takeda Company Information &nbsp;13.3.2 Takeda Glucagon Like Peptide 2 Receptor Product Portfolios and Specifications &nbsp;13.3.3 Takeda Glucagon Like Peptide 2 Receptor Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.3.4 Takeda Main Business Overview &nbsp;13.3.5 Takeda Latest Developments &nbsp;13.4 Tasly Pharmaceutical Group Co Ltd &nbsp;13.4.1 Tasly Pharmaceutical Group Co Ltd Company Information &nbsp;13.4.2 Tasly Pharmaceutical Group Co Ltd Glucagon Like Peptide 2 Receptor Product Portfolios and Specifications &nbsp;13.4.3 Tasly Pharmaceutical Group Co Ltd Glucagon Like Peptide 2 Receptor Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.4.4 Tasly Pharmaceutical Group Co Ltd Main Business Overview &nbsp;13.4.5 Tasly Pharmaceutical Group Co Ltd Latest Developments &nbsp;13.5 Zealand Pharma AS &nbsp;13.5.1 Zealand Pharma AS Company Information &nbsp;13.5.2 Zealand Pharma AS Glucagon Like Peptide 2 Receptor Product Portfolios and Specifications &nbsp;13.5.3 Zealand Pharma AS Glucagon Like Peptide 2 Receptor Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.5.4 Zealand Pharma AS Main Business Overview &nbsp;13.5.5 Zealand Pharma AS Latest Developments 14 Research Findings and Conclusion

Report	Global Glucagon Like Peptide 2 Receptor Market Growth 2025-2031
Selected License	Multi ID: LPI23590

Buyer Information

Order Summary